The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
作者信息
Perzanowski A, Bielawiec M, Myśliwiec M
出版信息
Folia Haematol Int Mag Klin Morphol Blutforsch. 1976;103(3):381-8.
PMID:63425
Abstract
摘要
相似文献
1
The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.苯乙双胍加美坦巴长期治疗对动脉硬化患者血液纤溶活性、血小板黏附性及脂质代谢的影响。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1976;103(3):381-8.
2
The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.苯乙双胍加司坦唑醇对复发性静脉血栓形成患者纤维蛋白溶解、血小板黏附性及血脂的影响
Folia Haematol Int Mag Klin Morphol Blutforsch. 1974;101(3):483-8.
3
Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.通过长期增强纤溶作用预防复发性静脉血栓形成。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(5-6):971-6.
4
Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.合成代谢类固醇对纤溶系统长期激活作用的临床研究。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):223-9.
5
6
Platelet-suppressive therapy in cardiovascular disease.
Cardiovasc Clin. 1984;14(3):211-34.
7
8
9
[Effects of clofibrate on fibrinolysis and platelet adhesiveness and aggregation in patients with arteriosclerosis].
Boll Soc Ital Cardiol. 1973;18(4):361-7.
10
Platelet adhesiveness and fibrinolytic activity in diabetes mellitus before and after therapy.糖尿病治疗前后的血小板黏附性和纤溶活性
J Assoc Physicians India. 1991 Oct;39(10):784.
Zotero 插件